Programmed death ligand-1 expression as immunotherapeutic target in sinonasal cancer
Publication date: | 2018 |
Publisher version: | http://dx.doi.org/10.1002/hed.25067 |
Citación: | Head and Neck, 40(4), p. 818-827 (2018); doi:10.1002/hed.25067 |
Descripción física: | p. 818-827 |
ISSN: | 1043-3074 |
DOI: | 10.1002/hed.25067 |
Patrocinado por: |
This study was funded by grants PI13-646 and PI15-1629 from the Fondos de Investigacion Sanitaria (FIS), grant RD12/0036/0015 from the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), and from the Centro de Investigacion Biomedica en Red de Cancer (CIBERONC) grant CB16/12/00390, Spain. Plan Nacional de I+D+I 2008-2011 of the Plan Estatal de I+D+I 2013-2016, cofinanced by the FEDER Funding Program from the European Union. |
Id. Proyecto: |
FIS/PI13-646 RD12/0036/0015 CB16/12/00390 FEDER |
Collections
- Artículos [27599]
